| Product Code: ETC7540905 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India coronary artery disease therapeutics market import shipment demonstrated remarkable growth with a high CAGR from 2020 to 2024. The market accelerated notably between 2023 and 2024, indicating a strong upward momentum and sustained expansion over the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Coronary Artery Disease Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Coronary Artery Disease Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Coronary Artery Disease Therapeutics Market - Industry Life Cycle |
3.4 India Coronary Artery Disease Therapeutics Market - Porter's Five Forces |
3.5 India Coronary Artery Disease Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Coronary Artery Disease Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Coronary Artery Disease Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 High prevalence of coronary artery disease in India |
4.2.2 Increasing awareness about the importance of early diagnosis and treatment |
4.2.3 Growing adoption of advanced therapeutics and technologies in healthcare sector |
4.3 Market Restraints |
4.3.1 High cost of coronary artery disease therapeutics |
4.3.2 Limited access to healthcare services, especially in rural areas |
4.3.3 Stringent regulatory requirements for drug approval and market entry |
5 India Coronary Artery Disease Therapeutics Market Trends |
6 India Coronary Artery Disease Therapeutics Market, By Types |
6.1 India Coronary Artery Disease Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Statins, 2021- 2031F |
6.1.4 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Beta-blockers, 2021- 2031F |
6.1.5 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.1.6 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By ACE Inhibitors, 2021- 2031F |
6.1.7 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Antiplatelet Drugs, 2021- 2031F |
6.1.8 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Coronary Artery Disease Therapeutics Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.4 India Coronary Artery Disease Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
7 India Coronary Artery Disease Therapeutics Market Import-Export Trade Statistics |
7.1 India Coronary Artery Disease Therapeutics Market Export to Major Countries |
7.2 India Coronary Artery Disease Therapeutics Market Imports from Major Countries |
8 India Coronary Artery Disease Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed treatment plans |
8.2 Rate of adoption of new therapeutic interventions |
8.3 Average time taken for diagnosis and initiation of treatment |
9 India Coronary Artery Disease Therapeutics Market - Opportunity Assessment |
9.1 India Coronary Artery Disease Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Coronary Artery Disease Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Coronary Artery Disease Therapeutics Market - Competitive Landscape |
10.1 India Coronary Artery Disease Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Coronary Artery Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here